Skip to content

Exagen Inc. XGN Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$3.97M+15.1%-$4.67M+34.1%-$7.09M-59.7%-$4.44M-18.3%-$3.75M+0.2%
$655K-7.1%$705K+18.9%$593K+33.9%$443K+6.2%$417K-3.7%
-$10.42M-246%-$3.01M-$2.89M+73.0%-$10.67M
$228K+418%$44K-84.0%$275K+31.6%$209K+85.0%$113K-22.6%
-$228K-551%-$35K+87.3%-$275K-31.6%-$209K-95.3%-$107K+26.7%
$168K+1.8%$165K+1.9%$162K+2.5%$158K+47.7%$107K
-$62K$0-100%$2.95M-86.5%$21.93M+34,370%-$64K+70.4%
-$10.71M$5.62M-70.2%$18.84M+274%-$10.84M
-$10.65M-248%-$3.06M-$3.09M+71.3%-$10.78M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Exagen Inc. generate?
Exagen Inc. (XGN) generated -$27.0M in operating cash flow over the trailing twelve months.
What is Exagen Inc.'s free cash flow?
After $756.0K of capital expenditures, Exagen Inc.'s free cash flow was -$27.6M over the trailing twelve months, down 96.9% year over year.
Where does Exagen Inc.'s cash flow data come from?
Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.